Skip to main content

Dr. Peter Q. Jiang, M.D., PH.D

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
39
In the NPI registry since
2006
Medicare patients seen, 2024
596

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    MI license 4301075266 · GA license 59981

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
596
Services billed
2,270
Patients’ average age
75
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes1,239438
Established patient office or other outpatient visit, 40-54 minutes264118
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes23091
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes19282
Established patient office or other outpatient visit, 20-29 minutes136124
New patient office or other outpatient visit, 45-59 minutes8484
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes6357
New patient office or other outpatient visit, 60-74 minutes3434
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes3125
New patient office or other outpatient visit, 30-44 minutes1212

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 16 companies reported 27 payments worth $9,783 in total to this clinician.

By type
Consulting Fee$8,565
Food and Beverage$602
Travel and Lodging$413
Education$203

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Apr 14, 2025Astellas Pharma US Inc
Apr 14, 2025
Consulting Fee
Vyloy · Oncology
$2,000
Oct 22, 2025AstraZeneca Pharmaceuticals LP
Oct 22, 2025
Consulting Fee$1,650
May 16, 2025AstraZeneca Pharmaceuticals LP
May 16, 2025
Consulting Fee$1,375
May 28, 2025AstraZeneca Pharmaceuticals LP
May 28, 2025
Consulting Fee
IMFINZI · Oncology
$1,100
Mar 15, 2025Incyte Corporation
Mar 15, 2025
Consulting Fee$860
Apr 30, 2025Geron Corporation
Apr 30, 2025
Consulting Fee
RYTELO · MYELODYSPLASTIC SYNDROME
$780
Sep 22, 2025Daiichi Sankyo Inc.
Sep 22, 2025
Consulting Fee
Vanflyta · ONCOLOGY
$650
Apr 4, 2025Astellas Pharma US Inc
Apr 4, 2025
Travel and Lodging
Vyloy · Oncology · travel to Phoenix, AZ
$267
Jul 11, 2025Janssen Scientific Affairs, LLC
Jul 11, 2025
Consulting Fee
TALVEY · Oncology
$150
Apr 4, 2025Astellas Pharma US Inc
Apr 4, 2025
Travel and Lodging
Vyloy · Oncology · travel to Phoenix, AZ
$123
All 14 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Oct 22, 2025AstraZeneca Pharmaceuticals LP
Oct 22, 2025
Consulting Fee$1,650
Oct 13, 2025Gilead Sciences, Inc.
Oct 13, 2025
Education
Trodelvy · ONC · in-kind
Company’s description;4203836;GTF;10894711
$77.99
Oct 6, 2025Janssen Biotech, Inc.
Oct 6, 2025
Education
DARZALEX; TALVEY; TECVAYLI · Oncology · in-kind
$99.99
Sep 22, 2025Daiichi Sankyo Inc.
Sep 22, 2025
Consulting Fee
Vanflyta · ONCOLOGY
$650
Jul 11, 2025Janssen Scientific Affairs, LLC
Jul 11, 2025
Consulting Fee
TALVEY · Oncology
$150
Jun 10, 2025Genmab U.S., Inc.
Jun 10, 2025
Education
Epkinly · Oncology · in-kind
$25.00
May 28, 2025AstraZeneca Pharmaceuticals LP
May 28, 2025
Consulting Fee
IMFINZI · Oncology
$1,100
May 16, 2025AstraZeneca Pharmaceuticals LP
May 16, 2025
Consulting Fee$1,375
Apr 30, 2025Geron Corporation
Apr 30, 2025
Consulting Fee
RYTELO · MYELODYSPLASTIC SYNDROME
$780
Apr 14, 2025Astellas Pharma US Inc
Apr 14, 2025
Consulting Fee
Vyloy · Oncology
$2,000
Apr 4, 2025Astellas Pharma US Inc
Apr 4, 2025
Travel and Lodging
Vyloy · Oncology · travel to Phoenix, AZ
$267
Apr 4, 2025Astellas Pharma US Inc
Apr 4, 2025
Travel and Lodging
Vyloy · Oncology · travel to Phoenix, AZ
$123
Apr 4, 2025Astellas Pharma US Inc
Apr 4, 2025
Travel and Lodging
Vyloy · Oncology · travel to Phoenix, AZ
$23.50
Mar 15, 2025Incyte Corporation
Mar 15, 2025
Consulting Fee$860

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Georgia →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $6,600 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology & Oncology clinicians in Columbus

Sources

NPI registry (CMS NPPES, November 2026; record last updated December 26, 2007), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1427067024. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.